Surrozen (NASDAQ:SRZN - Get Free Report) issued its quarterly earnings results on Friday. The company reported ($1.14) EPS for the quarter, topping the consensus estimate of ($1.23) by $0.09, Zacks reports. Surrozen had a negative net margin of 274.42% and a negative return on equity of 545.43%. The firm had revenue of $0.98 million during the quarter.
Surrozen Stock Up 7.9%
Shares of Surrozen stock traded up $0.79 during trading hours on Thursday, hitting $10.85. The company's stock had a trading volume of 65,602 shares, compared to its average volume of 14,197. Surrozen has a 1-year low of $5.90 and a 1-year high of $18.17. The business has a fifty day moving average of $9.20 and a 200 day moving average of $9.84. The company has a market capitalization of $92.88 million, a PE ratio of -0.75 and a beta of 0.60.
Institutional Investors Weigh In On Surrozen
A hedge fund recently raised its stake in Surrozen stock. Geode Capital Management LLC increased its position in Surrozen, Inc. (NASDAQ:SRZN - Free Report) by 22.6% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 30,963 shares of the company's stock after purchasing an additional 5,702 shares during the quarter. Geode Capital Management LLC owned 0.36% of Surrozen worth $277,000 as of its most recent filing with the Securities and Exchange Commission. Hedge funds and other institutional investors own 66.57% of the company's stock.
Wall Street Analyst Weigh In
Separately, HC Wainwright reaffirmed a "buy" rating and set a $32.00 price target on shares of Surrozen in a research report on Monday, May 12th.
View Our Latest Analysis on SRZN
About Surrozen
(
Get Free Report)
Surrozen, Inc, a clinical stage biotechnology company, discovers and develops drug candidates to selectively modulate the Wnt pathway for tissue repair. The company is developing antibody-based therapeutics which targets various disease areas, including diseases of the intestine, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas, and central nervous system.
Read More

Before you consider Surrozen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surrozen wasn't on the list.
While Surrozen currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.